Developer docs
API playgroundTry for free, no card

Search company profiles

PolarisRx

Full company profile

uuid0008rrs

Namestring
PolarisRx
Legal namestring
Polaris Pharmacy Services
Websiteurl
polarisrx.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Polaris Pharmacy Services (Polaris Rx) is an independent, privately held pharmacy services provider founded in 2015 and headquartered at 2900 NW 60th Street, Fort Lauderdale, Florida. It operates 20+ company-operated pharmacies (described as 26 strategically located satellite pharmacy locations) across FL, MI, MN, NC, MD, TN, PA, CA, VA, OH, NJ, MO and IL, and its correctional pharmacy business is licensed in all 50 states. Its customer base is dominated by care settings serving complex, high-risk populations: long-term care and post-acute facilities (skilled nursing, assisted living, hospice, behavioral health, PACE, and drug/alcohol recovery), correctional institutions and justice agencies ranging from small 20-bed facilities to prisons with an average daily population of 5,000, and specialty/infusion patients. Company-reported operating scale includes 1,000+ facilities serviced and 1M+ annual scripts processed, with a firmographic headcount band of 1,001-5,000. A fourth channel, direct-to-consumer, was added through the exclusive U.S. distribution of AstraZeneca's FluMist Home at-home nasal spray flu vaccine, where consumers order via flumist.com for home delivery.

The operating technology is a mix of proprietary software and third-party platforms rather than patent-protected or AI-based systems; no patents are listed and no public API is disclosed. Polaris operates proprietary ordering and claims systems (Pioneer and Framework), integrates with a wide range of eMAR/EHR platforms for real-time data exchange, and provides customer-facing tools including the PolarisConnect web portal (order tracking, drug quoting, invoices, returns, reporting), PolarisPrescribe secure HIPAA-compliant messaging and file sharing with encryption and archiving, PolarisDirect, and the Polaris At Home web-based post-discharge medication program. Physical infrastructure includes advanced cold chain capability at each of five dispensing locations for temperature-controlled biologics, and the CouplerRx-powered supply chain platform providing real-time inventory visibility and licensed FDA repackager capability. No AI/ML capabilities, research, models or data assets are disclosed anywhere in the source material.

Revenue is generated from six streams: per-prescription dispensing and delivery fees to long-term care and post-acute facilities; managed-services correctional contracts covering blister/unit dose/strip packaging, medication returns and reconciliation, MAT billing support and 340B program management; specialty and infusion dispensing reimbursed through payors and patient assistance programs; professional clinical services under PolarisCares (admissions assessment, PDPM clinical assessment, formulary management, pharmacogenomics review); manufacturer distribution and dispensing fees under the exclusive AstraZeneca FluMist Home agreement; and PolarisAcademy continuing education, which is positioned as customer engagement rather than a revenue line. Pricing is quote-based and contracted per facility or per inmate and negotiated with payors — no rate cards, plan tiers or price points are published. Go-to-market is a high-touch direct model in which each facility is supported by a dedicated care team of a customer care representative, nurse consultant and pharmacist, layered with a self-serve PolarisConnect portal, manufacturer and HUB co-marketing (AstraZeneca, Asembia, ASPN Pharmacies), and earned media. The company describes itself as independently and locally owned with no parent, no institutional investors, no disclosed funding rounds, no acquisitions and no disclosed revenue figure, which makes its financial profile materially less transparent than the public long-term care pharmacy comparables.

Short descriptiontext

Polaris Rx is an independent, privately held pharmacy services provider delivering clinical and correctional pharmacy programs to long-term care and post-acute facilities, justice agencies and specialty/infusion patients through 20+ company-operated pharmacies, and exclusive U.S. distribution of AstraZeneca's at-home FluMist vaccine.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersFort Lauderdale, United States
HQ citystring
Fort Lauderdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices18 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
long-term care pharmacy, correctional pharmacy services, specialty pharmacy, clinical pharmacy consulting, at-home vaccine distribution
Industry2 codes
PRIMARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
SECONDARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code2 codes
  • All Other Outpatient Care Centers621498
  • Offices of All Other Health Practitioners62139
SIC code2 codes
  • Retail-Drug Stores And Proprietary Stores5912
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Pharmacy Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model6 records
1Long-term care and post-acute pharmacy dispensing
TypeTransaction Fee
Description

Per-prescription dispensing and delivery services to skilled nursing, assisted living, hospice, behavioral, PACE and drug/alcohol recovery facilities, billed to facilities and payors, with recurring facility contracts and a dedicated care team per account enabling upsell of clinical programs.

polarisrx.com
2Correctional pharmacy services
TypeManaged Services
Description

Contracted pharmacy services to correctional institutions including blister/unit dose/strip packaging, medication returns and reconciliation, MAT program billing support, and 340B program management and reporting; recurring per-inmate/per-facility contracts.

polarisrx.com
3Specialty and infusion pharmacy
TypeTransaction Fee
Description

Specialty and infusion pharmacy solutions for complex, high-cost therapies delivered through dedicated specialty pharmacy operations, typically reimbursed through payors and patient assistance programs.

polarisrx.com
4Clinical and consulting services (PolarisCares)
TypeProfessional Services
Description

Professional clinical services — admissions assessment, PDPM clinical assessment, formulary management, pharmacogenomics review — sold to facilities to reduce pharmacy costs and optimize reimbursement; also coordinates specialty pharmacy fulfillment.

polarisrx.com
5Manufacturer distribution and specialty vaccine dispensing
TypeTransaction Fee
Description

Exclusive U.S. distribution and dispensing of AstraZeneca's FluMist Home at-home flu vaccine service, including cold chain handling, shipping to consumer homes and eligibility processing; a contract-based distribution/fulfilment revenue stream.

polarisrx.com
6Continuing education (PolarisAcademy)
TypeProfessional Services
Description

Free continuing education for facility administrators and nurses delivered onsite, via live webinars and through an online learning portal, used as a customer engagement and retention program rather than a direct revenue line.

polarisrx.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 7 records shown
1PolarisConnect
Description

Customer web portal providing pharmacy alert dashboard, drug quote management, invoice management, returns processing, report subscription, resource access and order tracking.

polarisrx.com
+6 more records
Core offering1 text field

Polaris Rx is an independent pharmacy organization that dispenses medications and delivers pharmacy services to care settings with complex, high-risk populations. Its core lines are long-term care and post-acute pharmacy services for skilled nursing, assisted living, hospice, behavioral, PACE and recovery facilities; correctional pharmacy services for jails, detention centers and prisons (unit dose/blister/strip packaging, medication returns, MAT and 340B program support); and specialty and infusion pharmacy for complex, high-cost therapies. It also acts as the exclusive U.S. distributor and dispenser of AstraZeneca's FluMist Home at-home nasal spray flu vaccine service, shipping to consumers' homes with cold chain handling.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Over 125 years of combined correctional pharmacy experience within the team, stated as unmatched by competitors
+4 more records
Product and service9 records
1Long-Term Care and Post-Acute Care Pharmacy Services
CategoryLong-term care pharmacy services
Description

Around-the-clock pharmacy care for residents of skilled nursing facilities, assisted living, hospice, behavioral health, PACE, and drug/alcohol recovery facilities, including per-prescription dispensing and delivery, emergency and first-dose onsite dispensing, and a dedicated care team (customer care representative, nurse consultant, pharmacist) for each facility account.

2Correctional Pharmacy Services
CategoryCorrectional pharmacy services
Description

Contracted pharmacy services for jails, detention centers, prisons and state/county justice agencies, including blister, unit dose and strip packaging, medication returns and reconciliation, diabetic supplies and wound care, MAT program billing and tracking, high-cost drug alternatives and therapeutic interchange, 340B program management and reporting, and eMAR integration, with 24/7 support and overnight delivery nationwide.

3Specialty and Infusion Pharmacy (Polaris Specialty Rx)
CategorySpecialty pharmacy services
Description

Dedicated specialty pharmacy operation dispensing complex, high-cost specialty and infusion therapies, typically reimbursed through payors and patient assistance programs, and coordinating specialty medication fulfillment with facility clinical services.

4PolarisCares Clinical Services
CategoryClinical and consulting pharmacy services
Description

Professional clinical pharmacy services sold to facilities, including admissions assessment, PDPM clinical assessment, formulary management and pharmacogenomics review, intended to reduce facility pharmacy costs and optimize reimbursement while coordinating specialty pharmacy fulfillment.

5PolarisConnect Customer Portal
CategoryCustomer portal / digital ordering and reporting
Description

Secure customer web portal for facility clients providing a pharmacy alert dashboard, drug quote management, invoice management, return processing, report subscription, resource access and order tracking.

6PolarisPrescribe Secure Messaging and File Sharing
CategorySecure clinical communication application
Description

Secure, HIPAA-compliant messaging and file-sharing application enabling verification, real-time alerts, notifications, time-stamping and read receipts, with in-app camera capture of secure images including controlled prescriptions (no image stored on device), cloud synchronization, full encryption and message archiving.

7Polaris At Home Medication Discharge Program
CategoryPost-discharge medication management program
Description

Web-based medication discharge program with electronic submissions and follow-up scheduling designed to prevent hospital readmissions and maintain medication compliance after discharge.

8Medicaid Pre-Release Coverage under Waiver 1115 (Justice-Involved Initiative)
CategoryManaged Medicaid / correctional pharmacy program
Description

Program supporting Medicaid pre-release coverage for justice-involved individuals in 19 approved states, including pre-release Medi-Cal enrollment, day-of-release dispensing of prescriptions and DME, MAT support and claims filing for justice-involved populations.

9Exclusive U.S. Distribution and Dispensing of AstraZeneca's FluMist Home At-Home Flu Vaccine Service
CategoryManufacturer distribution and specialty vaccine dispensing
Description

Contract-based exclusive U.S. distribution, dispensing and home shipment of FluMist Home nasal spray flu vaccine, with eligibility confirmation via flumist.com and cold chain handling at five dispensing locations, renewed for a second consecutive year.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1AstraZeneca
Strategic tierFlagshipTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-09-23
Description

Polaris Rx was named the exclusive U.S. distributor of AstraZeneca's FluMist Home service for the second consecutive year (announced 2026-09-23), following its selection for the 2025-2026 flu season. Through FluMist Home, consumers order FluMist nasal spray flu vaccine online for delivery directly to their home on a chosen date — the first program of its kind to receive FDA approval. Polaris dispenses and ships from five pharmacy locations with advanced cold chain capability.

marketscreener.com
2Asembia
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-08-21
Description

Asembia is Polaris' HUB services partner for the FluMist Home at-home flu vaccine program launched for the 2025-2026 flu season. Asembia supports the hub model that links the manufacturer, pharmacy distributor and consumer ordering/fulfilment flow for the service.

businesswire.com
3ASPN Pharmacies
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-08-21
Description

ASPN Pharmacies provides the technology platform and backend services for the FluMist Home launch, working alongside Polaris as the dispensing and shipping pharmacy distributor and Asembia as HUB services partner. Polaris began dispensing and shipping vaccines from five state-of-the-art pharmacy locations with cold chain capability.

businesswire.com
4CouplerRx
Strategic tierCoreTypeTechnology or Integration
Description

Polaris' correctional pharmacy supply chain is backed by CouplerRx, which provides real-time inventory visibility, fewer disruptions in medication availability, transparent consistent pricing, and licensed FDA repackager services.

polarisrx.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight9 records

Each record includes

Type, Description

Peers10 records
1PharMerica (BrightSpring Health Services)
TypeDirect peer
Description

The largest independent institutional (long-term care and post-acute) pharmacy operator in the U.S., now part of BrightSpring Health Services. It competes directly with Polaris for skilled nursing, assisted living and hospice facility contracts and is the scale benchmark Polaris explicitly differentiates itself from.

2Option Care Health
TypeDirect peer
Description

National home and alternate-site infusion and specialty pharmacy operator serving complex, high-cost therapies under payor reimbursement. It overlaps with Polaris Specialty Rx's infusion and high-cost therapy business and with Polaris's home-delivery orientation.

3Centauri Health Solutions
TypeDirect peer
Description

Specialty pharmacy and home infusion provider focused on complex therapies and payer/provider relationships, including pharmacy benefit services. It is a close analogue to the specialty and infusion segment Polaris is building out alongside its long-term care base.

4CivicaRx
TypeEmerging player
Description

Not-for-profit, non-profit health system-owned specialty pharmacy dispensing limited- and low-cost drugs for underserved patients. It is comparable on dispensing economics and payer-assistance programs in the high-cost specialty space where Polaris Specialty Rx operates.

5Capsule (Capsule Pharmacy)
TypeEmerging player
Description

Direct-to-consumer home-delivery online pharmacy with an app-led ordering and fulfillment model. It is the closest consumer-side analogue to Polaris's direct-to-consumer FluMist Home program at flumist.com.

6Alto Pharmacy
TypeEmerging player
Description

Home-delivery pharmacy built around a consumer-facing digital front end and same-day delivery. It is comparable to Polaris's attempt to own a consumer-facing at-home medication/vaccine channel through brand and partner infrastructure.

7Cardinal Health
TypeBroad incumbent
Description

Large healthcare company operating specialty pharmacy, manufacturer services, logistics and at-home solutions. It overlaps Polaris's specialty dispensing and manufacturer-distribution activities but does so as part of a much wider portfolio.

8Cencora (AmerisourceBergen)
TypeBroad incumbent
Description

Global pharmaceutical distributor providing manufacturer services, specialty distribution and logistics — the same functions Polaris performs in scaled form as exclusive U.S. distributor for AstraZeneca's FluMist Home and as an FDA-licensed repackager.

9McKesson
TypeBroad incumbent
Description

Leading pharmaceutical distributor and specialty pharmacy operator (McKesson Specialty) with manufacturer-facing services. It represents the scaled, vertically integrated alternative to Polaris's independent niche distribution and dispensing model.

10ASPN Pharmacies
TypeOthers
Description

Pharmacy technology platform and backend provider for the FluMist Home program and a broader pharmacy services platform for independent pharmacies. It is a named Polaris partner and technology dependency rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PolarisRx

Pharmacy Servicespolarisrx.com

Polaris Rx is an independent, privately held pharmacy services provider delivering clinical and correctional pharmacy programs to long-term care and post-acute facilities, justice agencies and specialty/infusion patients through 20+ company-operated pharmacies, and exclusive U.S. distribution of AstraZeneca's at-home FluMist vaccine.

What PolarisRx does

Polaris Pharmacy Services (Polaris Rx) is an independent, privately held pharmacy services provider founded in 2015 and headquartered at 2900 NW 60th Street, Fort Lauderdale, Florida. It operates 20+ company-operated pharmacies (described as 26 strategically located satellite pharmacy locations) across FL, MI, MN, NC, MD, TN, PA, CA, VA, OH, NJ, MO and IL, and its correctional pharmacy business is licensed in all 50 states. Its customer base is dominated by care settings serving complex, high-risk populations: long-term care and post-acute facilities (skilled nursing, assisted living, hospice, behavioral health, PACE, and drug/alcohol recovery), correctional institutions and justice agencies ranging from small 20-bed facilities to prisons with an average daily population of 5,000, and specialty/infusion patients. Company-reported operating scale includes 1,000+ facilities serviced and 1M+ annual scripts processed, with a firmographic headcount band of 1,001-5,000. A fourth channel, direct-to-consumer, was added through the exclusive U.S. distribution of AstraZeneca's FluMist Home at-home nasal spray flu vaccine, where consumers order via flumist.com for home delivery.

The operating technology is a mix of proprietary software and third-party platforms rather than patent-protected or AI-based systems; no patents are listed and no public API is disclosed. Polaris operates proprietary ordering and claims systems (Pioneer and Framework), integrates with a wide range of eMAR/EHR platforms for real-time data exchange, and provides customer-facing tools including the PolarisConnect web portal (order tracking, drug quoting, invoices, returns, reporting), PolarisPrescribe secure HIPAA-compliant messaging and file sharing with encryption and archiving, PolarisDirect, and the Polaris At Home web-based post-discharge medication program. Physical infrastructure includes advanced cold chain capability at each of five dispensing locations for temperature-controlled biologics, and the CouplerRx-powered supply chain platform providing real-time inventory visibility and licensed FDA repackager capability. No AI/ML capabilities, research, models or data assets are disclosed anywhere in the source material.

Revenue is generated from six streams: per-prescription dispensing and delivery fees to long-term care and post-acute facilities; managed-services correctional contracts covering blister/unit dose/strip packaging, medication returns and reconciliation, MAT billing support and 340B program management; specialty and infusion dispensing reimbursed through payors and patient assistance programs; professional clinical services under PolarisCares (admissions assessment, PDPM clinical assessment, formulary management, pharmacogenomics review); manufacturer distribution and dispensing fees under the exclusive AstraZeneca FluMist Home agreement; and PolarisAcademy continuing education, which is positioned as customer engagement rather than a revenue line. Pricing is quote-based and contracted per facility or per inmate and negotiated with payors — no rate cards, plan tiers or price points are published. Go-to-market is a high-touch direct model in which each facility is supported by a dedicated care team of a customer care representative, nurse consultant and pharmacist, layered with a self-serve PolarisConnect portal, manufacturer and HUB co-marketing (AstraZeneca, Asembia, ASPN Pharmacies), and earned media. The company describes itself as independently and locally owned with no parent, no institutional investors, no disclosed funding rounds, no acquisitions and no disclosed revenue figure, which makes its financial profile materially less transparent than the public long-term care pharmacy comparables.

PolarisRx firmographics

Firmographics
Name
PolarisRx
Legal name
Polaris Pharmacy Services
Website
https://polarisrx.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Polaris Rx is an independent, privately held pharmacy services provider delivering clinical and correctional pharmacy programs to long-term care and post-acute facilities, justice agencies and specialty/infusion patients through 20+ company-operated pharmacies, and exclusive U.S. distribution of AstraZeneca's at-home FluMist vaccine.
Ownership category
akta.pro rank

PolarisRx industry classification

Industry
Product category
Pharmacy Services
NAICS
All Other Outpatient Care Centers (621498), Offices of All Other Health Practitioners (62139)
SIC
Retail-Drug Stores And Proprietary Stores (5912), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYCRAOAHAA
Prescription Pharmaceutical (Rx) Wholesale Distribution
SECONDARYHLAGAKAM
Training & Competency Programs for GxP Compliance
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Long-term care pharmacy
  • Correctional pharmacy services
  • Specialty pharmacy
  • Clinical pharmacy consulting
  • At-home vaccine distribution

Where PolarisRx is headquartered

Location

Headquarters

HQ city
Fort Lauderdale
HQ country
United States
HQ region
North America

Offices18 records

Markets served

PolarisRx business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Long-term care and post-acute pharmacy dispensing: Per-prescription dispensing and delivery services to skilled nursing, assisted living, hospice, behavioral, PACE and drug/alcohol recovery facilities, billed to facilities and payors, with recurring facility contracts and a dedicated care team per account enabling upsell of clinical programs.
  2. Correctional pharmacy services: Contracted pharmacy services to correctional institutions including blister/unit dose/strip packaging, medication returns and reconciliation, MAT program billing support, and 340B program management and reporting; recurring per-inmate/per-facility contracts.
  3. Specialty and infusion pharmacy: Specialty and infusion pharmacy solutions for complex, high-cost therapies delivered through dedicated specialty pharmacy operations, typically reimbursed through payors and patient assistance programs.
  4. Clinical and consulting services (PolarisCares): Professional clinical services — admissions assessment, PDPM clinical assessment, formulary management, pharmacogenomics review — sold to facilities to reduce pharmacy costs and optimize reimbursement; also coordinates specialty pharmacy fulfillment.
  5. Manufacturer distribution and specialty vaccine dispensing: Exclusive U.S. distribution and dispensing of AstraZeneca's FluMist Home at-home flu vaccine service, including cold chain handling, shipping to consumer homes and eligibility processing; a contract-based distribution/fulfilment revenue stream.
  6. Continuing education (PolarisAcademy): Free continuing education for facility administrators and nurses delivered onsite, via live webinars and through an online learning portal, used as a customer engagement and retention program rather than a direct revenue line.

Go-to-market motion4 records

Distribution channels6 records

Marketing channels9 records

PolarisRx product offering

Product offering

Core offering

Polaris Rx is an independent pharmacy organization that dispenses medications and delivers pharmacy services to care settings with complex, high-risk populations. Its core lines are long-term care and post-acute pharmacy services for skilled nursing, assisted living, hospice, behavioral, PACE and recovery facilities; correctional pharmacy services for jails, detention centers and prisons (unit dose/blister/strip packaging, medication returns, MAT and 340B program support); and specialty and infusion pharmacy for complex, high-cost therapies. It also acts as the exclusive U.S. distributor and dispenser of AstraZeneca's FluMist Home at-home nasal spray flu vaccine service, shipping to consumers' homes with cold chain handling.

Differentiator

Problem solved

Functional benefit

Brands

  • PolarisConnect: Customer web portal providing pharmacy alert dashboard, drug quote management, invoice management, returns processing, report subscription, resource access and order tracking.
  • PolarisCares
  • Polaris At Home
  • PolarisDirect
  • PolarisPrescribe
  • PolarisAcademy
  • Polaris Specialty Rx

Products and services

  • Long-Term Care and Post-Acute Care Pharmacy Services Around-the-clock pharmacy care for residents of skilled nursing facilities, assisted living, hospice, behavioral health, PACE, and drug/alcohol recovery facilities, including per-prescription dispensing and delivery, emergency and first-dose onsite dispensing, and a dedicated care team (customer care representative, nurse consultant, pharmacist) for each facility account.
  • Correctional Pharmacy Services Contracted pharmacy services for jails, detention centers, prisons and state/county justice agencies, including blister, unit dose and strip packaging, medication returns and reconciliation, diabetic supplies and wound care, MAT program billing and tracking, high-cost drug alternatives and therapeutic interchange, 340B program management and reporting, and eMAR integration, with 24/7 support and overnight delivery nationwide.
  • Specialty and Infusion Pharmacy (Polaris Specialty Rx) Dedicated specialty pharmacy operation dispensing complex, high-cost specialty and infusion therapies, typically reimbursed through payors and patient assistance programs, and coordinating specialty medication fulfillment with facility clinical services.
  • PolarisCares Clinical Services Professional clinical pharmacy services sold to facilities, including admissions assessment, PDPM clinical assessment, formulary management and pharmacogenomics review, intended to reduce facility pharmacy costs and optimize reimbursement while coordinating specialty pharmacy fulfillment.
  • PolarisConnect Customer Portal Secure customer web portal for facility clients providing a pharmacy alert dashboard, drug quote management, invoice management, return processing, report subscription, resource access and order tracking.
  • PolarisPrescribe Secure Messaging and File Sharing Secure, HIPAA-compliant messaging and file-sharing application enabling verification, real-time alerts, notifications, time-stamping and read receipts, with in-app camera capture of secure images including controlled prescriptions (no image stored on device), cloud synchronization, full encryption and message archiving.
  • Polaris At Home Medication Discharge Program Web-based medication discharge program with electronic submissions and follow-up scheduling designed to prevent hospital readmissions and maintain medication compliance after discharge.
  • Medicaid Pre-Release Coverage under Waiver 1115 (Justice-Involved Initiative) Program supporting Medicaid pre-release coverage for justice-involved individuals in 19 approved states, including pre-release Medi-Cal enrollment, day-of-release dispensing of prescriptions and DME, MAT support and claims filing for justice-involved populations.
  • Exclusive U.S. Distribution and Dispensing of AstraZeneca's FluMist Home At-Home Flu Vaccine Service Contract-based exclusive U.S. distribution, dispensing and home shipment of FluMist Home nasal spray flu vaccine, with eligibility confirmation via flumist.com and cold chain handling at five dispensing locations, renewed for a second consecutive year.

Quantifiable outcome

  • Over 125 years of combined correctional pharmacy experience within the team, stated as unmatched by competitors
  • +4 more outcomes

Companies that use PolarisRx

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles5 records

PolarisRx technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

Feature8 records

PolarisRx partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered flagship and core.

  • AstraZenecaflagshipChannel Partner/ Reseller/ Distributor · 23 September 2026Polaris Rx was named the exclusive U.S. distributor of AstraZeneca's FluMist Home service for the second consecutive year (announced 2026-09-23), following its selection for the 2025-2026 flu season. Through FluMist Home, consumers order FluMist nasal spray flu vaccine online for delivery directly to their home on a chosen date — the first program of its kind to receive FDA approval. Polaris dispenses and ships from five pharmacy locations with advanced cold chain capability.
  • AsembiacoreTechnology or Integration · 21 August 2025Asembia is Polaris' HUB services partner for the FluMist Home at-home flu vaccine program launched for the 2025-2026 flu season. Asembia supports the hub model that links the manufacturer, pharmacy distributor and consumer ordering/fulfilment flow for the service.
  • ASPN PharmaciescoreTechnology or Integration · 21 August 2025ASPN Pharmacies provides the technology platform and backend services for the FluMist Home launch, working alongside Polaris as the dispensing and shipping pharmacy distributor and Asembia as HUB services partner. Polaris began dispensing and shipping vaccines from five state-of-the-art pharmacy locations with cold chain capability.
  • CouplerRxcoreTechnology or IntegrationPolaris' correctional pharmacy supply chain is backed by CouplerRx, which provides real-time inventory visibility, fewer disruptions in medication availability, transparent consistent pricing, and licensed FDA repackager services.

Scale indicators13 records

Recent moves7 records

Expansion highlights9 records

PolarisRx competitors and assessment

Company assessment

Direct peers

  • PharMerica (BrightSpring Health Services): The largest independent institutional (long-term care and post-acute) pharmacy operator in the U.S., now part of BrightSpring Health Services. It competes directly with Polaris for skilled nursing, assisted living and hospice facility contracts and is the scale benchmark Polaris explicitly differentiates itself from.
  • Option Care Health: National home and alternate-site infusion and specialty pharmacy operator serving complex, high-cost therapies under payor reimbursement. It overlaps with Polaris Specialty Rx's infusion and high-cost therapy business and with Polaris's home-delivery orientation.
  • Centauri Health Solutions: Specialty pharmacy and home infusion provider focused on complex therapies and payer/provider relationships, including pharmacy benefit services. It is a close analogue to the specialty and infusion segment Polaris is building out alongside its long-term care base.

Emerging players

  • CivicaRx: Not-for-profit, non-profit health system-owned specialty pharmacy dispensing limited- and low-cost drugs for underserved patients. It is comparable on dispensing economics and payer-assistance programs in the high-cost specialty space where Polaris Specialty Rx operates.
  • Capsule (Capsule Pharmacy): Direct-to-consumer home-delivery online pharmacy with an app-led ordering and fulfillment model. It is the closest consumer-side analogue to Polaris's direct-to-consumer FluMist Home program at flumist.com.
  • Alto Pharmacy: Home-delivery pharmacy built around a consumer-facing digital front end and same-day delivery. It is comparable to Polaris's attempt to own a consumer-facing at-home medication/vaccine channel through brand and partner infrastructure.

Broad incumbents

  • Cardinal Health: Large healthcare company operating specialty pharmacy, manufacturer services, logistics and at-home solutions. It overlaps Polaris's specialty dispensing and manufacturer-distribution activities but does so as part of a much wider portfolio.
  • Cencora (AmerisourceBergen): Global pharmaceutical distributor providing manufacturer services, specialty distribution and logistics — the same functions Polaris performs in scaled form as exclusive U.S. distributor for AstraZeneca's FluMist Home and as an FDA-licensed repackager.
  • McKesson: Leading pharmaceutical distributor and specialty pharmacy operator (McKesson Specialty) with manufacturer-facing services. It represents the scaled, vertically integrated alternative to Polaris's independent niche distribution and dispensing model.

Others

  • ASPN Pharmacies: Pharmacy technology platform and backend provider for the FluMist Home program and a broader pharmacy services platform for independent pharmacies. It is a named Polaris partner and technology dependency rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

PolarisRx social profiles

Digital presence

PolarisRx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PolarisRx leadership team

Management profile

Number of profiles

Profiles10 records

PolarisRx funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PolarisRx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PolarisRx

What does PolarisRx do?

Polaris Rx is an independent pharmacy organization that dispenses medications and delivers pharmacy services to care settings with complex, high-risk populations. Its core lines are long-term care and post-acute pharmacy services for skilled nursing, assisted living, hospice, behavioral, PACE and recovery facilities; correctional pharmacy services for jails, detention centers and prisons (unit dose/blister/strip packaging, medication returns, MAT and 340B program support); and specialty and infusion pharmacy for complex, high-cost therapies. It also acts as the exclusive U.S. distributor and dispenser of AstraZeneca's FluMist Home at-home nasal spray flu vaccine service, shipping to consumers' homes with cold chain handling.

Is PolarisRx a public or private company?

PolarisRx is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was PolarisRx founded?

PolarisRx was founded in 2015. It employs 501 to 1,000 people.

Where is PolarisRx based?

PolarisRx is headquartered in Fort Lauderdale, United States, in the North America region.

How does PolarisRx make money?

Six revenue lines are on record. Long-term care and post-acute pharmacy dispensing is the primary driver. The others are correctional pharmacy services, specialty and infusion pharmacy, clinical and consulting services (PolarisCares), manufacturer distribution and specialty vaccine dispensing and continuing education (PolarisAcademy).

Who are PolarisRx's main competitors?

Direct peers on record are PharMerica (BrightSpring Health Services), Option Care Health and Centauri Health Solutions. Emerging players are CivicaRx, Capsule (Capsule Pharmacy) and Alto Pharmacy. Broad incumbents are Cardinal Health, Cencora (AmerisourceBergen) and McKesson. ASPN Pharmacies is listed as an others.

Does PolarisRx have an API?

No public API is recorded for PolarisRx.

What industry is PolarisRx in?

PolarisRx's product category is Pharmacy Services. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of HLAGAKAM, Training & Competency Programs for GxP Compliance. Its NAICS code is 621498 and its SIC code is 5912.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogPolaris Rx Selected by Bristol Myers Squibb to Dispense ZENBEXUS™ (iberdomide), the First FDA-Approved CELMoD Therapy for Multiple MyelomaPolaris Rx was selected by Bristol Myers Squibb to dispense ZENBEXUS, the first FDA-approved cereblon-modulating protein degrader for multiple myeloma. The drug, approved in combination with daratumumab and dexamethasone, showed 41% MRD-negative complete response in the EXCALIBER-RRMM trial. Continued approval may depend on confirmatory trial results.FinancialContent Business PagePolaris Rx Selected by Bristol Myers Squibb to Dispense ZENBEXUS™ (iberdomide), the First FDA-Approved CELMoD Therapy for Multiple MyelomaPolaris Rx was selected by Bristol Myers Squibb to dispense ZENBEXUS, the first FDA-approved cereblon-modulating protein degrader for multiple myeloma. The drug, approved in combination with daratumumab, hyaluronidase-fihj, and dexamethasone, was granted accelerated approval on August 13, 2026, based on the EXCALIBER-RRMM trial, where 41% of patients achieved MRD-negative complete response.MarketScreenerPolaris Rx And AstraZeneca Name Polaris Rx Exclusive U.S. Distributor Of AstraZeneca's FluMist® Home Service For Second Consecutive YearPolaris Rx was named exclusive U.S. distributor for AstraZeneca's FluMist Home at-home flu vaccine service for the 2026-2027 flu season, marking the second consecutive year. The service is now available in all 48 contiguous states.Business Wire BlogPolaris Rx Named Exclusive U.S. Distributor of AstraZeneca's FluMist® Home Service for Second Consecutive YearPolaris Rx was named exclusive U.S. distributor of AstraZeneca's FluMist Home for the 2026-2027 flu season, its second consecutive year. The at-home nasal spray vaccine is available in all 48 contiguous states, with Polaris Rx dispensing from two pharmacy locations.FinancialContent Business PagePolaris Rx Named Exclusive U.S. Distributor of AstraZeneca's FluMist® Home Service for Second Consecutive YearPolaris Rx was named exclusive U.S. distributor of AstraZeneca's FluMist Home for the 2026-2027 flu season, its second consecutive year. The FDA-approved at-home nasal spray vaccine is available in all 48 contiguous states. Polaris Rx continues its partnership with Asembia and ASPN Pharmacies.Business Wire BlogPolaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca’s FluMist® Home Service—The World’s First At-Home Nasal Spray Flu VaccinePolaris Pharmacy Services was named exclusive U.S. distributor of AstraZeneca's FluMist Home, the first FDA-approved at-home nasal spray flu vaccine, for the 2025-2026 season. The service allows online ordering and home delivery without a doctor's visit, with Polaris dispensing from five pharmacy locations.YahooPolaris Pharmacy Services Named Exclusive U.S. Distributor of AstraZeneca’s FluMist® Home Service—The World’s First At-Home Nasal Spray Flu VaccinePolaris Pharmacy Services has been named the exclusive U.S. distributor for FluMist Home, AstraZeneca's FDA-approved at-home nasal spray flu vaccine service for the 2025-2026 flu season. The program, the first of its kind to receive FDA approval, allows individuals to order FluMist online for home delivery without a doctor's visit. Polaris has begun dispensing and shipping vaccines from five pharmacy locations equipped with specialized cold chain capabilities, with Asembia and ASPN Pharmacies serving as operational partners.PR NewswireCUBEX® LLC MedBank™ Solutions Expands Partnership with Polaris Pharmacy ServicesCUBEX LLC's MedBank Medical Solutions is expanding its partnership with Polaris Pharmacy Services to equip new pharmacies in Michigan, Minnesota, and Florida with automated medication management devices. This deployment aims to reduce labor costs and enhance security for controlled substances through MedBank Mini and Tower technology. The expansion leverages MedBank's regulatory compliance features to support Polaris's growth into additional states.